1. Home
  2. BX vs KLTOW Comparison

BX vs KLTOW Comparison

Compare BX & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BX
  • KLTOW
  • Stock Information
  • Founded
  • BX 1985
  • KLTOW N/A
  • Country
  • BX United States
  • KLTOW United States
  • Employees
  • BX N/A
  • KLTOW 3
  • Industry
  • BX Investment Managers
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BX Finance
  • KLTOW Health Care
  • Exchange
  • BX Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • BX 105.4B
  • KLTOW N/A
  • IPO Year
  • BX 2007
  • KLTOW 2022
  • Fundamental
  • Price
  • BX $155.13
  • KLTOW $0.24
  • Analyst Decision
  • BX Buy
  • KLTOW
  • Analyst Count
  • BX 16
  • KLTOW 0
  • Target Price
  • BX $159.38
  • KLTOW N/A
  • AVG Volume (30 Days)
  • BX 3.4M
  • KLTOW N/A
  • Earning Date
  • BX 07-24-2025
  • KLTOW N/A
  • Dividend Yield
  • BX 2.55%
  • KLTOW N/A
  • EPS Growth
  • BX 16.59
  • KLTOW N/A
  • EPS
  • BX 3.31
  • KLTOW N/A
  • Revenue
  • BX $12,372,735,000.00
  • KLTOW N/A
  • Revenue This Year
  • BX N/A
  • KLTOW N/A
  • Revenue Next Year
  • BX $28.85
  • KLTOW N/A
  • P/E Ratio
  • BX $46.92
  • KLTOW N/A
  • Revenue Growth
  • BX 24.64
  • KLTOW N/A
  • 52 Week Low
  • BX $115.66
  • KLTOW N/A
  • 52 Week High
  • BX $200.96
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • BX 70.82
  • KLTOW N/A
  • Support Level
  • BX $148.57
  • KLTOW N/A
  • Resistance Level
  • BX $152.67
  • KLTOW N/A
  • Average True Range (ATR)
  • BX 3.45
  • KLTOW 0.00
  • MACD
  • BX 1.61
  • KLTOW 0.00
  • Stochastic Oscillator
  • BX 97.66
  • KLTOW 0.00

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.167 trillion in total asset under management, including $860.1 billion in fee-earning assets under management, at the end of March 2025. The company has four core business segments: private equity (26% of fee-earning AUM and 30% of base management fees), real estate (34% and 40%), credit and insurance (32% and 23%), and multi-asset investing (8% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: